Corient Private Wealth’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Corient Private Wealth's HALO Position: Q2 2026 in Review
Corient Private Wealth reduced its Halozyme (HALO) stake by 1.8% in Q2 2026, selling an estimated $240K and leaving 187,166 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #520.
Corient Private Wealth first reported a position in HALO in Q4 2022 and has held it in 14 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Corient Private Wealth held 187,166 shares of Halozyme worth $14.6M as of Q2 2026.
- Corient Private Wealth sold 3,518 Halozyme shares in Q2 2026, an estimated $240K.
- Halozyme made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #520 holding.
- Corient Private Wealth first reported a position in Halozyme in Q4 2022 and has held it in 14 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.